Ausgabe 6/2019
Inhalt (26 Artikel)
Up front
Digital health technology and mobile devices for the management of diabetes mellitus: state of the art
Rongzi Shan, Sudipa Sarkar, Seth S. Martin
NAD+ metabolism as a target for metabolic health: have we found the silver bullet?
Niels J. Connell, Riekelt H. Houtkooper, Patrick Schrauwen
Canagliflozin should be prescribed with caution to individuals with type 2 diabetes and high risk of amputation
Matilde Monteiro-Soares, Inês Ribeiro-Vaz, Edward J. Boyko
Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis
Caroline K. Kramer, Sara Campbell, Ravi Retnakaran
A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial
Mireille N. M. van Poppel, David Simmons, Roland Devlieger, F. Andre van Assche, Goele Jans, Sander Galjaard, Rosa Corcoy, Juan M. Adelantado, Fidelma Dunne, Jürgen Harreiter, Alexandra Kautzky-Willer, Peter Damm, Elisabeth R. Mathiesen, Dorte M. Jensen, Lise-Lotte Andersen, Mette Tanvig, Annunziata Lapolla, Maria G. Dalfra, Alessandra Bertolotto, Ewa Wender-Ozegowska, Agnieszka Zawiejska, David Hill, Frank J. Snoek, Judith G. M. Jelsma, Gernot Desoye
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
David R. Matthews, Qiang Li, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Mehul Desai, William R. Hiatt, Mark Nehler, Elisa Fabbrini, Mary Kavalam, Mary Lee, Bruce Neal
Lower limb events in individuals with type 2 diabetes: evidence for an increased risk associated with diuretic use
Louis Potier, Ronan Roussel, Gilberto Velho, Pierre-Jean Saulnier, Anisoara Bumbu, Odette Matar, Fabrice Schneider, Stéphanie Ragot, Michel Marre, Kamel Mohammedi, Samy Hadjadj
Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study
Robert S. Rosenson, Martha L. Daviglus, Yehuda Handelsman, Paolo Pozzilli, Harold Bays, Maria Laura Monsalvo, Mary Elliott-Davey, Ransi Somaratne, Peter Reaven
Pre-diagnostic plasma enterolactone concentrations are associated with lower mortality among individuals with type 2 diabetes: a case-cohort study in the Danish Diet, Cancer and Health cohort
Anne K. Eriksen, Cecilie Kyrø, Natalja P. Nørskov, Kirsten Frederiksen, Knud-Erik Bach Knudsen, Kim Overvad, Rikard Landberg, Anne Tjønneland, Anja Olsen
Eighteen-year alcohol consumption trajectories and their association with risk of type 2 diabetes and its related factors: the China Health and Nutrition Survey
Tianshu Han, Shuang Zhang, Wei Duan, Xinhui Ren, Chunbo Wei, Changhao Sun, Ying Li
Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis
Sarah A. Aroner, Jeremy D. Furtado, Frank M. Sacks, Michael Y. Tsai, Kenneth J. Mukamal, Robyn L. McClelland, Majken K. Jensen
Macrophage alterations in islets of obese mice linked to beta cell disruption in diabetes
Jeng Yie Chan, Kailun Lee, Emma L. Maxwell, Cassandra Liang, D. Ross Laybutt
Pregnancy in human IAPP transgenic mice recapitulates beta cell stress in type 2 diabetes
Tatyana Gurlo, Sarah Kim, Alexandra E. Butler, Chang Liu, Lina Pei, Madeline Rosenberger, Peter C. Butler
No direct effect of SGLT2 activity on glucagon secretion
Rune E. Kuhre, Seyed M. Ghiasi, Alice E. Adriaenssens, Nicolai J. Wewer Albrechtsen, Daniel B. Andersen, Alexander Aivazidis, Lihua Chen, Thomas Mandrup-Poulsen, Cathrine Ørskov, Fiona M. Gribble, Frank Reimann, Nils Wierup, Björn Tyrberg, Jens J. Holst
Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study
Thomas Bryrup, Cæcilie W. Thomsen, Timo Kern, Kristine H. Allin, Ivan Brandslund, Niklas R. Jørgensen, Henrik Vestergaard, Torben Hansen, Tue H. Hansen, Oluf Pedersen, Trine Nielsen
Imaging mass spectrometry enables molecular profiling of mouse and human pancreatic tissue
Boone M. Prentice, Nathaniel J. Hart, Neil Phillips, Rachana Haliyur, Audra Judd, Radhika Armandala, Jeffrey M. Spraggins, Cindy L. Lowe, Kelli L. Boyd, Roland W. Stein, Christopher V. Wright, Jeremy L. Norris, Alvin C. Powers, Marcela Brissova, Richard M. Caprioli
Effects of long-term exercise on plasma adipokine levels and inflammation-related gene expression in subcutaneous adipose tissue in sedentary dysglycaemic, overweight men and sedentary normoglycaemic men of healthy weight
Sindre Lee, Frode Norheim, Torgrim M. Langleite, Hanne L. Gulseth, Kåre I. Birkeland, Christian A. Drevon
Elevated brain glutamate levels in type 1 diabetes: correlations with glycaemic control and age of disease onset but not with hypoglycaemia awareness status
Evita C. Wiegers, Hanne M. Rooijackers, Jack J.A. van Asten, Cees J. Tack, Arend Heerschap, Bastiaan E. de Galan, Marinette van der Graaf
Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes
Ying Cheng, Xiaochen Yu, Jie Zhang, Yunpeng Chang, Mei Xue, Xiaoyu Li, Yunhong Lu, Ting Li, Ziyu Meng, Long Su, Bei Sun, Liming Chen
Impaired whole-body heat loss in type 1 diabetes during exercise in the heat: a cause for concern?
Sean R. Notley, Martin P. Poirier, Jane E. Yardley, Ronald J. Sigal, Glen P. Kenny
Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus
Chantal Kopecky, Yuliya Lytvyn, Oliver Domenig, Marlies Antlanger, Johannes J. Kovarik, Christopher C. Kaltenecker, Marko Poglitsch, Bruce A. Perkins, Kerry-Anne Rye, David Z. I. Cherney, Marcus D. Säemann
Underpowered or negative? A crucial distinction
Ole L. Dollerup, Jonas T. Treebak, Niels Jessen
Underpowered or negative? A crucial distinction. Reply to Dollerup OL, Treebak JT, Jessen N [letter]
Niels J. Connell, Riekelt H. Houtkooper, Patrick Schrauwen
Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence
Oskar Skog, Karin Klingel, Merja Roivainen, Olle Korsgren
Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]
Jessica L. Dunne, Sarah J. Richardson, Mark A. Atkinson, Maria E. Craig, Knut Dahl-Jørgensen, Malin Flodström-Tullberg, Heikki Hyöty, Richard E. Lloyd, Noel G. Morgan, Alberto Pugliese